SANDLER LAURA LEE (Chief Operating Officer) sold 2.1% of their position (5K shares) of ORUKA THERAPEUTICS, INC. on the open market
Open‑market sale worth $472.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 7/1/2026ACC: 0000907654-26-000069
Officer· Chief Operating Officer
Since Mar 2026
-5K
Net shares
Net seller
$472.1K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
5K acquired · 10K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+5K
Price / share
$7.80
Trade value
$39K
% of position
2.1%
7/1/2026
236.38K→241.38K
Common Stock
Direct
Shares
−2.24K
Price / share
$93.85
Trade value
$209.93K
% of position
0.9%
7/1/2026
241.38K→239.15K
Common Stock
Direct
Shares
−2.26K
Price / share
$94.75
Trade value
$214.41K
% of position
0.9%
7/1/2026
239.15K→236.88K
Common Stock
Direct
Shares
−500.00
Price / share
$95.47
Trade value
$47.74K
% of position
0.2%
7/1/2026
236.88K→236.38K
Total
Net shares
+0.00
Net value
-$433.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | M · Option Exercise | +5K | $7.80 | $39K | 2.1% | 236.38K | 241.38K |
| Common Stock Direct | 7/1/2026 | S · Sale | −2.24K | $93.85 | $209.93K | 0.9% | 241.38K | 239.15K |
| Common Stock Direct | 7/1/2026 | S · Sale | −2.26K | $94.75 | $214.41K | 0.9% | 239.15K | 236.88K |
| Common Stock Direct | 7/1/2026 | S · Sale | −500.00 | $95.47 | $47.74K | 0.2% | 236.88K | 236.38K |
| Total | +0.00 | -$433.08K | ||||||
Derivative Transactions1
Employee Warrant (right to buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
7.80
Held after
80K
Exercisable
—
7/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Warrant (right to buy) Direct | Common Stock5K shares | 7/1/2026 | M · Option Exercise | −5K | 7.80 | — | 80K |